Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45a3703d03a4b21be619937f5ad63b8b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04 |
filingDate |
2012-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9a30ab21d77c1a44aeaaaa4bf7f7a2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_400daff922cb848d9b93874a05aa5680 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0b1e0ffb408a7c53028711f7dd91112 |
publicationDate |
2013-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013101623-A1 |
titleOfInvention |
Attenuated mycobacterial strain as novel vaccine against tuberculosis |
abstract |
The present invention provides a novel attenuated vaccine for tuberculosis. Furthermore, when used as a subcutaneous vaccine, the present invention induces a higher level of protection than the current vaccine. Finally, the present invention results in less tissue damage and a lower number of colony forming units (CFU) in the lungs compared to subjects vaccinated with BCG. |
priorityDate |
2010-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |